News
STVN
14.74
-0.20%
-0.03
Top and lowest-rated mid-cap stocks heading into earnings
Seeking Alpha · 2d ago
Weekly Report: what happened at STVN last week (0406-0410)?
Weekly Report · 2d ago
Undervalued Growth Story: Strong Contractual Visibility and Expanding Margins Support Buy Rating
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: Stevanato Group (STVN), Elevance Health (ELV) and Integer Holdings (ITGR)
TipRanks · 04/08 07:11
Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings
Seeking Alpha · 04/07 15:05
Weekly Report: what happened at STVN last week (0330-0403)?
Weekly Report · 04/06 09:52
Weekly Report: what happened at STVN last week (0323-0327)?
Weekly Report · 03/30 09:52
Stevanato Group management to meet with KeyBanc
TipRanks · 03/23 17:30
Weekly Report: what happened at STVN last week (0316-0320)?
Weekly Report · 03/23 09:49
AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights
Seeking Alpha · 03/18 05:35
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Stevanato Group (STVN) and BioNTech SE (BNTX)
TipRanks · 03/16 12:40
Weekly Report: what happened at STVN last week (0309-0313)?
Weekly Report · 03/16 09:49
Mid-Cap healthcare stocks ranked by quant ratings after earnings season
Seeking Alpha · 03/14 14:50
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
Barchart · 03/12 15:45
Stevanato Group Posts 2025 Growth on High-Value Syringes and GLP‑1 Demand
TipRanks · 03/12 00:44
Weekly Report: what happened at STVN last week (0302-0306)?
Weekly Report · 03/09 09:50
Stevanato Group Earnings Call Highlights High-Value Surge
TipRanks · 03/08 00:15
Stevanato Group Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 03/06 16:12
Stevanato Group Price Target Cut to $19.00/Share From $24.00 by Morgan Stanley
Dow Jones · 03/06 16:12
Morgan Stanley Maintains Equal-Weight on Stevanato Group, Lowers Price Target to $19
Benzinga · 03/06 16:03
More
Webull provides a variety of real-time STVN stock news. You can receive the latest news about Stevanato Group S P A through multiple platforms. This information may help you make smarter investment decisions.
About STVN
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.